Zhou, H., Zhang, Y., Zhou, M. M., Choi, S. K., Reynolds, K., Harrison, T. N., Bellows, B. K., Moran, A. E., Colantonio, L. D., Allen, N. B., Safford, M. M., & An, J. (2025). Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association, 14(4). https://doi.org/10.1161/jaha.124.039454

Gomez, M. L., Beecham, G., Montine, T. J., Cuccaro, M. L., Toga, A. W., Keene, C. D., Crane, P. K., Mukherjee, S., Panizzon, M. S., Biber, S. A., Kukull, W. A., Bennett, D. A., Barnes, L. L., Schneider, J. A., De Jager, P. L., Menon, V., Hohman, T. J., & Dumitrescu, L. C. (2024). Sex Specific Association of Apolipoprotein E Alleles with Autopsy Measures of Arteriolosclerosis and Atherosclerosis among Older Adults. Alzheimer’s & Dementia, 20(S1). Portico. https://doi.org/10.1002/alz.091485

Zhang, Y., An, J., Xia, M., Zhou, H., Sun, Y., Chung, J., Zhou, M., Choi, S. K., Morrissette, K. L., Muntner, P., Safford, M. M., Isasi, C. R., Kanaya, A. M., Bellows, B. K., Colantonio, L. D., Reynolds, K., & Moran, A. E. (2024). Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease. PLOS ONE, 19(10), e0312756. https://doi.org/10.1371/journal.pone.0312756

Kohli-Lynch, C., Thanassoulis, G., Pencina, M., Sehayek, D., Pencina, K., Moran, A., & Sniderman, A. D. (2024). Reply. JACC: Advances, 3(9), 101090. https://doi.org/10.1016/j.jacadv.2024.101090

Kuno, T., Miyamoto, Y., Akita, K., Shoji, S., Numasawa, Y., Ueda, I., Noma, S., Fukuda, K., & Kohsaka, S. (2024). Low-Dose Prasugrel vs. Standard-Dose Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention. Circulation Journal. https://doi.org/10.1253/circj.cj-24-0173

Reyes-Soffer, G., Yeang, C., Michos, E. D., Boatwright, W., & Ballantyne, C. M. (2024). High lipoprotein(a): Actionable strategies for risk assessment and mitigation. American Journal of Preventive Cardiology, 18, 100651. https://doi.org/10.1016/j.ajpc.2024.100651

Huang, P., Ran, J., Zhu, W., Dai, W., Tang, Y., Lian, P., Huang, X., & Li, R. (2024). PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine‐induced hepatic steatosis via both receptor‐dependent and receptor‐independent pathways. The FASEB Journal, 38(4). Portico. https://doi.org/10.1096/fj.202301748r

Groenen, A. G., Matveyenko, A., Matienzo, N., Halmos, B., Zhang, H., Westerterp, M., & Reyes-Soffer, G. (2024). Apolipoprotein(a) production and clearance are associated with plasma IL-6 and IL-18 levels, dependent on ethnicity. Atherosclerosis, 391, 117474. https://doi.org/10.1016/j.atherosclerosis.2024.117474

Wang, Y., Tinsley, B., Spolitu, S., Zadroga, J. A., Agarwal, H., Sarecha, A. K., & Ozcan, L. (2024). Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9. Journal of Lipid Research, 65(3), 100515. https://doi.org/10.1016/j.jlr.2024.100515

Kohli-Lynch, C., Thanassoulis, G., Pencina, M., Sehayek, D., Pencina, K., Moran, A., & Sniderman, A. D. (2024). The Causal-Benefit Model to Prevent Cardiovascular Events. JACC: Advances, 3(3), 100825. https://doi.org/10.1016/j.jacadv.2023.100825

Laing, K. K., McQuaid, C., Lao, P. J., Chagnot, A., Stefancova, D., Garcia, D. J., Fialova, N., Brickman, A. M., Wardlaw, J. M., & Montagne, A. (2023). Apolipoprotein E Status Mediates Pericyte Recruitment Mechanisms in the Presence of Excess Cholesterol. Alzheimer’s & Dementia, 19(S14). Portico. https://doi.org/10.1002/alz.078978

Gordy, D., Francis, R., & Stone, E. (2023). Using an agonist panel and aggregation to assess antiplatelet therapy in mice. American Journal of Clinical Pathology, 160(Supplement_1), S142–S142. https://doi.org/10.1093/ajcp/aqad150.306

Arce Rentería, M., McClure, L. A., Callas, P. W., LaBode-Richman, V. M., Kroll, D. S., Manly, J. J., Zakai, N. A., Unverzagt, F., & Cushman, M. (2023). Lipoprotein(a) and risk of cognitive impairment in Black and White Americans: the Reasons for Geographic and Racial Differences in Stroke cohort. Research and Practice in Thrombosis and Haemostasis, 7(6), 102170. https://doi.org/10.1016/j.rpth.2023.102170

Kalia, I., Shope, R., Reilly, M., & Schwartz, L. (2023). Addressing the underdiagnosis of familial hypercholesterolemia: A mixed methods study exploring the knowledge and practice behaviors of cardiology healthcare providers. Journal of Clinical and Translational Science, 7(1). https://doi.org/10.1017/cts.2023.519

Dikilitas, O., Sherafati, A., Saadatagah, S., Satterfield, B. A., Kochan, D. C., Anderson, K. C., Chung, W. K., Hebbring, S. J., Salvati, Z. M., Sharp, R. R., Sturm, A. C., Gibbs, R. A., Rowley, R., Venner, E., Linder, J. E., Jones, L. K., Perez, E. F., Peterson, J. F., Jarvik, G. P., … Kullo, I. J. (2023). Familial Hypercholesterolemia in the Electronic Medical Records and Genomics Network: Prevalence, Penetrance, Cardiovascular Risk, and Outcomes After Return of Results. Circulation: Genomic and Precision Medicine, 16(2). https://doi.org/10.1161/circgen.122.003816

Kalia, I., Shope, R., Reilly, M., & Schwartz, L. (2023). 256 Addressing the Underdiagnosis of Familial Hypercholesterolemia. Journal of Clinical and Translational Science, 7(s1), 78–78. https://doi.org/10.1017/cts.2023.320

Cubeddu, R. J., Murphy, S. M. E., Asher, C. R., Garcia, S. A., Granada, J. F., Don, C. W., Patel, S., Albaghdadi, M. S., Cavalcante, J. L., Coylewright, M., Hahn, R. T., Genereux, P., Yadav, P. K., Thourani, V. H., & Leon, M. B. (2023). Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data. American Heart Journal, 258, 27–37. https://doi.org/10.1016/j.ahj.2022.12.012

An, J., Zhang, Y., Zhou, H., Zhou, M., Safford, M. M., Muntner, P., Moran, A. E., & Reynolds, K. (2023). Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk. Journal of the American College of Cardiology, 81(7), 623–632. https://doi.org/10.1016/j.jacc.2022.11.051

Sharma, T., Maehara, A., Ben-Yehuda, O., Maeng, M., Kjoller-Hansen, L., Engstrom, T., Matsumura, M., Frobert, O., Persson, J., Wiseth, R., Larsen, A. I., James, S. K., Ali, Z. A., Stone, G. W., & Erlinge, D. (2022). Biomarkers associated with vulnerable plaques. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1292

Kohli-Lynch, C. N., Lewsey, J., Boyd, K. A., French, D. D., Jordan, N., Moran, A. E., Sattar, N., Preiss, D., & Briggs, A. H. (2022). Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Circulation, 145(17), 1312–1323. https://doi.org/10.1161/circulationaha.121.057631